摘要
目的：探讨复方丹参注射液在早中期肝硬化的疗效并进行分析.方法：选自我院收入的早中期肝硬化患者75例,分为两组,观察组共38例患者,对照组37例患者.对照组给予口服肌苷片0.4g,每天三次.三磷酸腺苷片40mg,每天三次,氨基酸注射液250ml静脉滴注,每天一次.观察组除上述药物外再给予复方丹参注射液20ml于5%葡糖糖注射液250ml中静脉滴注,每天一次.检测两组患者肝功能指标以及肝纤维化的指标,并进行评估.结果：使用复发丹参注射液后患者的肝功能指标TBIL、ALT,肝纤维化指标AH、LN、C-IV等均与对照组相比有显著改变,两组对比有统计学意义.结论：复方丹参注射液在早中期肝硬化的治疗中效果显著,值得临床大力推广.
Objective：The discussion compound prescription salvia miltiorrhiza inoculation tluid and carries on the analysis at tlae early intermediate stage liver cirrhosis curative effect. Methods：Chooses the self-courtyard income the early intermediate stage liver cirrhosis patient 75 examples, divides into two groups, the observation group altogether 38 example patients, the control group 37 example patients. The control group gives takes orally myo- glucoside piece 0.4g, daily three times. Three adenylic acid glucoside piece 40mg,daily three times,amino acid inoculation fluid 250ml vein drop note, daily time. The observation group gives compound prescription salvia miltiorrhiza inoculation fluid 20ml again besides the above medicine in 5% glucose sugar inoculation fluid 250ml median vein drop note,daily time. Examines two group of patient liver function target as well as the liver fibrosis target,and carries on the appraisal. Results：Use recrudescence salvia miltiorrhiza inoculation fluid future trouble liver function target TBIL, ALT,liver fibrosis target AH, LN,C-IV and so on compare with the control group have the remarkable change, two groups of contrasts has statistics significance. Conclusion：The compound prescription salvia miltiorrhiza inoculation fluid the effect is remarkable at in the early intermediate stage liver cirrhosis treatment,is worth promoting vigorously clinically.
出处
《按摩与康复医学》
2011年第3期122-123,共2页
Chinese Manipulation and Rehabilitation Medicine
关键词
复方丹参注射液
肝硬化
肝纤维化
The compound prescription salvia miltiorrhiza inoculation fluid Liver cirrhosis Liver fibrosis
